[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@monaco_biotech Avatar @monaco_biotech Monaco

Several biopharmaceutical companies have recently made announcements regarding clinical trials, partnerships, and financial offerings. Notably, companies such as Atai Life Sciences, Praxis Precision Medicines, and Rapt Therapeutics have announced public offerings, while others like Summit Therapeutics and Regeneron have shared updates on their oncology portfolios and pipeline advancements. Additionally, companies like Viridian Therapeutics and Cargo Therapeutics have made announcements regarding public offerings and acquisitions.

Engagements: XXXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence countries XXXXX% stocks XXXX% finance XXXX% cryptocurrencies XXXX% currencies XXX%

Social topic influence $fulc #4, $kymr #17, kymera #6, $idya #6, $tara #49, $adct 1.81%, $biib 1.81%, $gpcr #16, $prax 1.2%, $rgnx XXX%

Top accounts mentioned or mentioned by @aaronrosenblum5 @justiceforb_md @seedy19tron @karensmithfl @saicharanaitha @joserestonva @threadanddoc @rezfszubagoly @oncinvestor @andre_agtc @pencilvester999 @senormargarita @jeremyj0916 @tuduni90782 @tallnfat @svarre001 @biohazard3737 @snupsnus @avidresearch @justiceforbmd

Top assets mentioned Kymera Therapeutics, Inc. Common Stock (KYMR) IDEAYA Biosciences, Inc. Common Stock (IDYA) Taraxa (TARA) ADC Therapeutics SA (ADCT) Biogen Inc (BIIB) Praxis Precision Medicines, Inc. Common Stock (PRAX) Dyne Therapeutics, Inc. Common Stock (DYN) Sarepta Therapeutics, Inc. (SRPT) Neurocrine Biosciences, Inc. (NBIX) Cogent Biosciences, Inc. Common Stock (COGT) Insmed, Inc. (INSM) United Therapeutics, Corp. (UTHR) uniQure N.V. (QURE) Avidity Biosciences, Inc. Common Stock (RNA) Veeva Systems, Inc. (VEEV) Dawn Protocol (DAWN) AstraZeneca PLC (AZN) AltLayer (ALT) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Mirum Pharmaceuticals, Inc. Common Stock (MIRM) CG Oncology, Inc. Common stock (CGON) Arrowhead Research Corporation (ARWR) Janux Therapeutics, Inc. Common Stock (JANX) Crinetics Pharmaceuticals, Inc. (CRNX) Prothena Corporation plc Ordinary Shares (PRTA) Oruka Therapeutics, Inc. Common Stock (ORKA) Celcuity Inc. Common Stock (CELC) Royalty Pharma plc Class A Ordinary Shares (RPRX) Denali Therapeutics Inc. Common Stock (DNLI) Xenon Pharmaceuticals Inc (XENE) SATS (Ordinals) (SATS) Agios Pharmaceuticals, Inc. (AGIO) Wave Life Sciences Ltd. Ordinary Shares (WVE) Terns Pharmaceuticals, Inc. Common Stock (TERN)

Top Social Posts

Top posts by engagements in the last XX hours

"$PRAX Praxis AES Wrap-up: Best-in-Class Potential Across Rare Pediatric and Adult Epilepsies BioPharmCatalyst"
X Link 2025-12-08T13:14Z 6163 followers, 1592 engagements

"$RGNX REGENXBIO Presents Positive Twelve-Month Pivotal Data from Phase I/II/III CAMPSIITE Trial of RGX-12. - RGNX BioPharmCatalyst"
X Link 2025-09-05T11:08Z 6155 followers, 1438 engagements

"$ADCT ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update - ADCT BioPharmCatalyst"
X Link 2025-11-10T12:43Z 6151 followers, XXX engagements

"There is only one new 13-F that really interests me: DARWIN GLOBAL MANAGEMENT LTD $ABVX $INSM $UTHR $QURE"
X Link 2025-11-14T23:11Z 6152 followers, 33K engagements

"$TARA Conference call and live webcast at 8:30 a.m. ET on Wednesday November XX 2025 📌 Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase X STA. - TARA BioPharmCatalyst"
X Link 2025-11-18T21:32Z 6151 followers, 2309 engagements

"$RNA Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota. - RNA BioPharmCatalyst"
X Link 2025-11-19T14:15Z 6153 followers, 1632 engagements

"$VEEV $RHHBF Veeva Announces Expanded Partnership with Roche"
X Link 2025-11-24T12:15Z 6151 followers, 1163 engagements

"$BIIB Biogen and Dayra Therapeutics Announce Research Collaboration to Discover and Develop Oral Macrocycl. - BIIB BioPharmCatalyst"
X Link 2025-11-24T12:31Z 6150 followers, XXX engagements

"$DAWN Day One Announces Three Year Follow-Up Data From OJEMDA (tovorafenib) Phase X FIREFLY-1 Trial at th. - DAWN BioPharmCatalyst"
X Link 2025-11-24T13:18Z 6150 followers, 1399 engagements

"$BIIB Eisai Completes Rolling Submission to U.S. FDA for LEQEMBI IQLIK (lecanemab-irmb) Supplemental Bio. - BIIB BioPharmCatalyst"
X Link 2025-11-25T12:32Z 6151 followers, 1142 engagements

"$TARA Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase X ADV. - TARA BioPharmCatalyst"
X Link 2025-12-01T21:29Z 6151 followers, 2055 engagements

"$FENC Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study. - FENC BioPharmCatalyst"
X Link 2025-12-02T12:14Z 6155 followers, XXX engagements

"$AZN Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-. - AZN BioPharmCatalyst @avidresearch"
X Link 2025-12-02T14:18Z 6153 followers, 1616 engagements

"$ADCT Company to host corporate webcast to share updated data on December X 2025 📌 ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial - ADCT BioPharmCatalyst"
X Link 2025-12-02T21:29Z 6151 followers, 1483 engagements

"$BIIB New Data Presented at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025 Confirms Pha. - BIIB BioPharmCatalyst"
X Link 2025-12-02T21:41Z 6150 followers, 1279 engagements

"$ADCT ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combina. - ADCT BioPharmCatalyst"
X Link 2025-12-03T12:39Z 6151 followers, 1443 engagements

"$PRAX Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor BioPharmCatalyst"
X Link 2025-12-04T21:04Z 6150 followers, 7592 engagements

"$KYMR Kymera Therapeutics to Announce KT-621 BroADen Phase 1b Atopic Dermatitis Trial Results on December X 2025 BioPharmCatalyst @seedy19tron"
X Link 2025-12-06T03:20Z 6155 followers, 2429 engagements

"$RGNX REGENXBIO Announces FDA Review Extension of BLA for RGX-121 to Treat Patients with MPS II"
X Link 2025-08-18T21:03Z 6154 followers, 2773 engagements

"$TARA Protara Announces Proposed Public Offering BioPharmCatalyst"
X Link 2025-12-04T21:26Z 6154 followers, 1075 engagements

"$KYMR Kymera Therapeutics Presents New Preclinical Data for KT-579 a First-in-Class Oral IRF5 Degrader. - KYMR BioPharmCatalyst"
X Link 2025-10-27T11:15Z 6156 followers, 1148 engagements

"$TARA Protara Therapeutics Announces Positive Interim Results Demonstrating Robust Responses in the Ongoin. - TARA BioPharmCatalyst"
X Link 2025-11-19T13:08Z 6154 followers, 2487 engagements

"$ALT Altimmune Announces CEO Transition and Succession Plan - ALT BioPharmCatalyst"
X Link 2025-12-01T12:30Z 6161 followers, 1465 engagements

"$ABOS Acumen Pharmaceuticals Highlights Enhanced Brain Delivery Technology for Oligomer-Selective Antibod. - ABOS BioPharmCatalyst"
X Link 2025-12-02T13:22Z 6162 followers, 1057 engagements

"@SaicharanAitha Yes"
X Link 2025-12-08T01:49Z 6154 followers, XXX engagements

"@biopharmacaster Patience. People have to realize these amazing results $DYN. $SRPT should be toast on this news"
X Link 2025-12-08T11:46Z 6163 followers, 1006 engagements

"$RXRX Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at XX Weeks"
X Link 2025-12-08T12:33Z 6161 followers, 1123 engagements

"$MIRM Mirum Pharmaceuticals Enters into Definitive Agreement to Acquire Bluejay Therapeutics Expanding Global Leadership in Rare Disease BioPharmCatalyst"
X Link 2025-12-08T13:09Z 6157 followers, 1194 engagements

"$SABS SAB BIO to Present Data Showcasing Progress in the Development of SAB-142 at the Asian Conference on Innovative Therapies for Diabetes Management BioPharmCatalyst"
X Link 2025-12-08T13:11Z 6157 followers, 1230 engagements

"$ASRT Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN (clobazam) O. - ASRT BioPharmCatalyst"
X Link 2025-09-15T13:03Z 6163 followers, 1146 engagements

"$NBIX #fail Neurocrine Biosciences Provides Update on Phase X Study of NBI-1070770 in Adults with Major Depressi. - NBIX BioPharmCatalyst"
X Link 2025-11-10T21:10Z 6163 followers, 10.7K engagements

"$CGON CG Oncology Reports Third Quarter 2025 Financial Results and Provides Business Updates - CGON BioPharmCatalyst"
X Link 2025-11-14T13:19Z 6163 followers, XXX engagements

"$ARWR $SRPT Arrowhead Pharmaceuticals Earns $XXX Million Milestone Payment from Sarepta Therapeutics - SRPT BioPharmCatalyst"
X Link 2025-11-24T12:53Z 6163 followers, 1519 engagements

"$JANX Not anymore. Sold at a loss. The word "encouraging" was the signal to run lol 🚩❌"
X Link 2025-12-01T21:42Z 6163 followers, 8726 engagements

"$IDYA IDE034 a Bispecific ADC Licensed by Biocytogen to IDEAYA Receives FDA IND Clearance BioPharmCatalyst"
X Link 2025-12-05T00:05Z 6163 followers, 1739 engagements

"$FULC Fulcrum Therapeutics Announces Positive Initial Results from the XX mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting BioPharmCatalyst"
X Link 2025-12-06T22:50Z 6163 followers, 3998 engagements

"$SLS SELLAS Life Sciences Presents Positive Phase X Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025 BioPharmCatalyst"
X Link 2025-12-07T23:05Z 6163 followers, 2561 engagements

"$FULC Fulcrum Therapeutics Announces Proposed $XXXXX Million Public Offering of Common Stock BioPharmCatalyst"
X Link 2025-12-08T21:04Z 6163 followers, 1002 engagements

"$LXEO Added today new trading position for data event soon"
X Link 2025-12-09T18:37Z 6163 followers, 3396 engagements

"$KYMR @ $XXXXX Kymera Therapeutics Announces Pricing of Upsized $XXX Million Public Offering BioPharmCatalyst"
X Link 2025-12-10T09:15Z 6163 followers, 1292 engagements

"$FULC @ $XXXXX Fulcrum Therapeutics Announces Pricing of Upsized $XXXXX Million Public Offering of Common Stock and Pre-Funded Warrants BioPharmCatalyst"
X Link 2025-12-10T12:53Z 6163 followers, 1340 engagements

"$ABOS Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration Option and License Agr. - ABOS BioPharmCatalyst"
X Link 2025-07-15T11:16Z 6163 followers, XXX engagements

"$NBIX Neurocrine Biosciences Presents New Three-Year Data Demonstrating Sustained Clinical Benefits and Es. - NBIX BioPharmCatalyst"
X Link 2025-10-06T12:33Z 6164 followers, 3237 engagements

"$IDYA Much better picture now for my position. Keep going 💪🏻😃 Now only $CRNX is lagging behind"
X Link 2025-10-28T14:52Z 6164 followers, 3247 engagements

"$IDYA IDEAYA Biosciences Reports Third Quarter 2025 Financial Results and Provides Business Update - IDYA BioPharmCatalyst"
X Link 2025-11-04T11:02Z 6164 followers, 1232 engagements

"$PRTA Prothena Highlights Phase X Data for Coramitug (Formerly PRX004) Published in Circulation Official. - PRTA BioPharmCatalyst"
X Link 2025-11-11T14:14Z 6163 followers, 1933 engagements

"$ORKA Oruka Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - ORKA BioPharmCatalyst"
X Link 2025-11-12T21:07Z 6163 followers, XXX engagements

"There are definitely no traders with strong nerves in $IMMX 📈📉📈📉 whereas $GUTS and $QNRX are home to diamond hands. Data $IMMX at ASH December X and before that everyone will get FOMO lol"
X Link 2025-11-17T20:03Z 6163 followers, 1979 engagements

"$CELC Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatoli. - CELC BioPharmCatalyst"
X Link 2025-11-17T21:07Z 6164 followers, 1516 engagements

"$VRCA +11% 📈 pre-market Verrica Pharmaceuticals Announces Private Placement Financing of $XX Million to Retire Debt and Exte. - VRCA BioPharmCatalyst"
X Link 2025-11-24T13:05Z 6163 followers, 1168 engagements

"$IDYA IDEAYA Biosciences Announces IND Clearance for IDE034 a Potential First-in-Class Bispecific B7H3/PTK7 TOP1 ADC Targeting Multiple Solid Tumor Types"
X Link 2025-12-01T11:08Z 6163 followers, 2430 engagements

"$QTTB Q32 Bio Sells Complement Inhibitor ADX-097"
X Link 2025-12-01T12:03Z 6163 followers, 5015 engagements

"$FULC Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Po. - FULC BioPharmCatalyst"
X Link 2025-12-02T14:13Z 6164 followers, 2502 engagements

"$RPRX $DNLI Denali Therapeutics and Royalty Pharma Announce $XXX Million Royalty Funding Agreement BioPharmCatalyst"
X Link 2025-12-04T12:17Z 6163 followers, 1582 engagements

"$XENE Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025 BioPharmCatalyst"
X Link 2025-12-05T14:19Z 6164 followers, XXX engagements

"$SATS frisky 🔥 Not a bio but it might be worth risking a trade"
X Link 2025-12-08T02:00Z 6164 followers, 1161 engagements

"$AGIO Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia BioPharmCatalyst"
X Link 2025-12-08T12:03Z 6163 followers, 1694 engagements

"$KYMR Kymera Therapeutics Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader in Patients with Moderate to Severe Atopic Dermatitis BioPharmCatalyst"
X Link 2025-12-08T12:04Z 6163 followers, 1591 engagements

"Brief recap of my long tickets today. All sold with data spike today: $IMMX +11% 📈 $FULC +62% 📈 $DYN +15% 📈 $GPCR +150% 📈 * $WVE +158% 📈 $TERN +35% 📈 * Unfortunately sold a little too early. I'm not a fan of having too many stocks in my longterm port so I'm waiting for the financings and then picking out 1-2 gems. $GPCR is definitely one of them"
X Link 2025-12-08T20:45Z 6163 followers, 4954 engagements

"$KYMR Kymera Therapeutics Announces Proposed Public Offering BioPharmCatalyst"
X Link 2025-12-08T21:03Z 6163 followers, 2200 engagements

"@lame_karma Congrats. Now that the binaries are done it's time to see who has the most buyout potential. Not an easy task but I see $GPCR at the top of the list. $COGT too. And I agree that $FULC also belong in the inner circle. Too many good names at the moment"
X Link 2025-12-08T23:35Z 6163 followers, XXX engagements

"$COGT I have added to my existing long-term position. I am deeply convinced that this stock is a candidate for a buyout that at least 2-3 big pharma will be fighting over. Thanks for the dips. I will continue to accumulate ✌🏻🤑"
X Link 2025-12-09T18:20Z 6163 followers, 10.8K engagements

"$IDYA IDEAYA Biosciences Announces IND Submission for IDE574 a Potential First-In-Class KAT6/7 Dual Inhibitor for Breast and Lung Cancers BioPharmCatalyst"
X Link 2025-12-10T11:20Z 6163 followers, 1354 engagements

"Who is actually selling $FULC just because the offer price is $XXXXX In a few days many will be grateful to the sellers jmho. Watch and learn 🤓"
X Link 2025-12-10T13:37Z 6163 followers, 2552 engagements